higher-strength form of Retrovir (zidovudine, AZT)

Glaxo is introducing a higher-strength form of Retrovir (zidovudine, AZT)...300 mg tablets for BID dosing.

The original 100 mg capsules are usually given 2 caps TID.

The new tablets will be more convenient...especially for patients on the popular Retrovir/Epivir combo, since Epivir is also given BID.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote